Cryoglobulinemia (Review)

Molecular Medicine Reports

Volumn 6, Issue 1, 2012, Pages 3-8

  Takada, Shimon ^a   Shimizu, Taro ^b   Hadano, Yoshiro ^c   Matsumoto, Kentaro ^d   Kataoka, Yuki ^e   Arima, Yu ^f   Inoue, Toshiya ^g   Sorano, Sumire ^h  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

^b EMORY UNIVERSITY   (United States)

^c SHIZUOKA CANCER CENTER   (Japan)

^d National Medical Clinic   (Japan)

^e HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^f Mimihara General Hospital   (Japan)

^g RAKUWAKAI OTOWA HOSPITAL   (Japan)

^h KOBE UNIVERSITY   (Japan)

Author keywords

Cryoglobulinemia; Hepatitis C virus; Immunoglobulins; Purpuric papule; Rituximab; Vasculitis

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PEGINTERFERON; PEGINTERFERON ALPHA; PREDNISONE; RIBAVIRIN; RITUXIMAB; STEROID;

ANTIGEN ANTIBODY COMPLEX; ARTHRALGIA; CLINICAL FEATURE; COLLAGEN DISEASE; CRYOGLOBULINEMIA; DISEASE PREDISPOSITION; FATIGUE; GLOMERULONEPHRITIS; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY DIAGNOSIS; LOW TEMPERATURE; LYMPHOPROLIFERATIVE DISEASE; MYALGIA; NEUROPATHY; PALLIATIVE THERAPY; PATHOGENESIS; PLASMAPHERESIS; PRECIPITATION; PROGNOSIS; PURPURA; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT INDICATION; TREATMENT OUTCOME; VASCULITIS; WARMING;

CRYOGLOBULINEMIA; HEPATITIS C, CHRONIC; HUMANS; PROGNOSIS;

HEPATITIS C VIRUS;

EID: 84861581225     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.861     Document Type: Review

References (77)

1. Wintrobe M and Buell M: Hyperproteinemia associated with multiple myeloma: With report of a case in which an extraordinary hyperproteinemia was associated with thrombosis of the retinal veins and symptoms suggesting Raynaud's disease. Bull Johns Hopkins Hosp 52: 156-165, 1933.
2. Brouet JC, Clauvel JP, Danon F, Klein M and Seligmann M: Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57: 775-788, 1974.
3. Jennette JC, Falk RJ, Andrassy K, et al: Nomenclature of systemic vasculitides: Proposal of an international consensus conference. Arthritis Rheum 37:187-192, 1994. (Pubitemid 24065492)
4. Trendelenburg M and Schifferli JA: Cryoglobulins are not essential. Ann Rheum Dis 57: 3-5, 1998. (Pubitemid 28175211)
5. Bonnet F, Pineau JJ, Taupin JL, et al: Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients. J Rheumatol 30: 2005-2010, 2003. (Pubitemid 37075552)
6. García-Carrasco M, Ramos-Casals M, Cervera R, et al: Cryoglobulinemia in systemic lupus erythematosus: prevalence and clinical characteristics in a series of 122 patients. Semin Arthritis Rheum 30: 366-373, 2001. (Pubitemid 32298862)
7. Ramos-Casals M, Cervera R, Yagüe J, et al: Cryoglobulinemia in primary Sjögren's syndrome: prevalence and clinical characteristics in a series of 115 patients. Semin Arthritis Rheum 28: 200-205, 1998. (Pubitemid 28563932)
8. Cicardi M, Cesana B, Del Ninno E, et al: Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C. J Viral Hepat 7: 138-143, 2000. (Pubitemid 30177104)
9. Ramos-Casals M, Muñoz S, Medina F, et al: Systemic auto-immune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry). J Rheumatol 36: 1442-1448, 2009.
10. Ferri C, Zignego AL and Pileri SA: Cryoglobulins (review). J Clin Pathol 55: 4-13, 2002. (Pubitemid 34081673)
11. Meltzer M, Franklin EC, Elias K, McCluskey RT and Cooper N: Cryoglobulinemia - A clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 40: 837-856, 1966.
12. Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P and Franklin E: Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 69: 287-308, 1980. (Pubitemid 10036826)
13. Invernizzi F, Galli M, Serino G, Monti G, Meroni PL, Granatieri C and Zanussi C: Secondary and essential cryoglobulinemias. Frequency, nosological classification, and long-term follow-up. Acta Haematol 70: 73-82, 1983. (Pubitemid 13076858)
14. Monti G, Galli M, Invernizzi F, Pioltelli P, Saccardo F, Monteverde A, Pietrogrande M, Renoldi P, Bombardieri S, Bordin G, et al: Cryoglobulinaemias: a multi-center study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. QJM 88: 115-126, 1995.
15. Dammacco F and Sansonno D: Mixed cryoglobulinemia as a model of systemic vasculitis. Clin Rev Allergy Immunol 15: 97-119, 1997. (Pubitemid 127499097)
16. Lamprecht P, Gause A and Gross WL: Cryoglobulinemic vasculitis. Arthritis Rheum 42: 2507-2516, 1999. (Pubitemid 30327166)
17. Ferri C, Antonelli A, Mascia MT, Sebastiani M, Fallahi P, Ferrari D, Pileri SA and Zignego AL: HCV-related autoimmune and neoplastic disorders: the HCV syndrome. Dig Liver Dis 39: S13-S21, 2007. (Pubitemid 47541920)
18. Ferri C, Antonelli A, Mascia MT, Sebastiani S, Fallhai P, Ferrari D, Giunti M, Pileri SA and Zignego AL: B-cells and mixed cryoglobulinemia. Autoimmun Rev 7: 114-120, 2007. (Pubitemid 350116722)
19. Mascia MT, Ferrari D, Campioli D, Sandri G, Mussini C and Ferri C: Non HCV-related mixed cryoglobulinemia. Dig Liver Dis 39: S61-S64, 2007. (Pubitemid 47541924)
20. Ferraccioli GF, De Vita S, Casatta L, et al: Autoimmune connective tissue disease, chronic polyarthritides and B cell expansion: risks and perspectives with immunosuppressive drugs. Clin Exp Rheumatol 14: S71-S80, 1996. (Pubitemid 26127970)
21. Pileri P, Uematsu Y, Campagnoli S, et al: Binding of hepatitis C virus to CD81. Science 282: 938-941, 1998. (Pubitemid 28507525)
22. Schott P, Polzien F, Müller-Issberner A, et al: In vitro reactivity of cryoglobulin IgM and IgG in hepatitis C virus-associated mixed cryoglobulinemia. J Hepatol 28: 17-26, 1998. (Pubitemid 28122495)
23. Ramos-Casals M, Trejo O, García-Carrasco M, et al: Mixed cryoglobulinemia: new concepts. Lupus 9: 83-91, 2000. (Pubitemid 30171103)
24. Weinberger A, Berliner S and Pinkhas J: Articular manifestations of essential cryoglobulinemia. Semin Arthritis Rheum 10: 224-229, 1981. (Pubitemid 11106802)
25. Santoro L, Manganelli F, Briani C, Giannini F, Benedetti L, Vitelli E, Mazzeo A, Beghi E; HCV Peripheral Nerve Study Group: Prevalence and characteristics of peripheral neuropathy in hepatitis C virus population. J Neurol Neurosurg Psychiatry 77: 626-629, 2006. (Pubitemid 43844587)
26. Montagnino G: Reappraisal of the clinical expression of mixed cryoglobulinemia: Springer Semin Immunopathol 10: 1-19, 1988.
27. Ferri C, La Civita L, Cirafisi C, et al: Peripheral neuropathy in mixed cryoglobulinemia. clinical and electrophysiologic investigations. J Rheumatol 19: 889-895, 1992.
28. Gemignani F, Pavesi G, Fiocchi A, et al: Peripheral neuropathy in essential mixed cryoglobulinaemia. J Neurol Neurosurg Psychiatry 55: 116-120, 1992.
29. Roccatello D, Fornasieri A, Giachino O, Rossi D, Beltrame A, Banfi G, Confalonieri R, Tarantino A, Pasquali S, Amoroso A, Savoldi S, Colombo V, Manno C, Ponzetto A, Moriconi L, Pani A, Rustichelli R, Di Belgiojoso GB, Comotti C and Quarenghi MI: Multicenter Study on Hepatitis C Virus-Related Cryoglobulinemic Glomerulonephritis. Am J Kidney Dis 49: 69-82, 2006.
30. Antonelli A, Ferri C, Fallahi P, Sebastiani M, Nesti C, Barani L, Barale R and Ferrannini E: Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. Rheumatology (Oxford) 43: 238-240, 2004. (Pubitemid 38219683)
31. Pozzato G, Mazzaro C, Crovatto M, Modolo ML, Ceselli S, Mazzi G, Sulfaro S, Franzin F, Tulissi P, Moretti M and Santini GF: Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 84: 3047-3053, 1994. (Pubitemid 24328097)
32. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi E, Romagnani S, Gentilini P and Bréchot C: Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 15: 382-386, 1992.
33. Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB; for the Italian Association of the Study of Liver Commission on Extrahepatic Manifestations of HCV infection: Extrahepatic manifestations of Hepatitis C Virus infection. a general overview and guidelines for a clinical approach. Dig Liver Dis 39 :2-17, 2007. (Pubitemid 46039435)
34. Monteverde A, Ballarè M and Pileri S: Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia. Springer Semin Imunopathol 19: 99-110, 1997. (Pubitemid 27417531)
35. Sansonno D, Tucci FA, De Re V, Lauletta G, Montrone M, Libra M and Dammacco F: HCV-associated B cell clonalities in the liver do not carry the t(14;18) chromosomal translocation. Hepatology 42: 1019-1027, 2005. (Pubitemid 43112668)
36. Giannini C, Giannelli F and Zignego AL: Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment. Hepatology 42: 1019-1027, 2005.
37. Manganelli P, Salaffi F, Subiaco S, Carotti M, Cervini C, Consigli G, Majori M and Pesci A: Bronchoalveolar lavage in mixed cryoglobulinaemia associated with hepatitis C virus. Br J Rheumatol 35: 978-982, 1996.
38. Machida K, Cheng KT, Sung VM, Shimodaira S, Lindsay KL, Levine AM, Lai MY and Lai MM: Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci USA 101: 4262-4267, 2004. (Pubitemid 38405917)
39. Migliaresi S, Bresciani A, Ambrosone L, Spera M, Barbarulo D, Lombari V, Pirozzi G, Borgia G, Lombardi ML, Tirri G and Manzo C: Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia. Ann Rheum Dis 59: 20-25, 2000. (Pubitemid 30303892)
40. Cohen, P, Nguyen, QT, Deny P, et al: Treatment of mixed cryoglobulinemia with recombinant interferon alpha and adjuvant therapies: A prospective study on 20 patients. Ann Med Interne (Paris) 147: 81-86, 1996.
41. Garcia-Bragado, F, Fernandez, JM, Navarro, C, et al: Peripheral neuropathy in essential mixed cryoglobulinemia. Arch Neurol 45: 1210-1214, 1988.
42. Chad, D, Pariser, K, Bradley, WG, et al: The pathogenesis of cryoglobulinemic neuropathy. Neurology 32: 725-729, 1982. (Pubitemid 12078050)
43. Nemni, R, Corbo, M, Fazio, R, et al: Cryoglobulinaemic neuropathy: A clinical, morphological and immunocytochemical study of 8 cases. Brain 111: 541-552, 1988.
44. Tredici, G, Petruccioli, MG, Cavaletti, G, et al: Sural nerve bioptic findings in essential cryoglobulinemic patients with and without peripheral neuropathy. Clin Neuropathol 11: 121-127, 1992.
45. Bonetti, B, Invernizzi, F, Rizzuto, N, et al: T-cell-mediated epineurial vasculitis and humoral-mediated microangiopathy in cryoglobulinemic neuropathy. J Neuroimmunol 73: 145-154, 1997. (Pubitemid 27105280)
46. Cavaletti, G, Petruccioli, MG, Crespi V, et al: A clinicopathological and follow up study of 10 cases of essential type II cryoglobulinaemic neuropathy. J Neurol Neurosurg Psychiatry 53: 886-889, 1990. (Pubitemid 20351054)
47. Ferri C and Mascia MT: Cryoglobulinemic vasculitis: Review. Curr Opin Rheumatol 18: 54-63, 2006.
48. Abel G, Zhang QX and Agnello V: Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum 36:1341-1349, 1993. (Pubitemid 23304201)
49. Ferri C, La Civita L, Longombardo G, et al: Mixed cryoglobulinemia: a cross-road between autoimmune and lymphoproliferative disorders. Lupus 7: 275-279, 1998. (Pubitemid 28264006)
50. Rockx MA and Clark WF: Plasma exchange for treating cryoglobulinemia: a descriptive analysis. Transfus Apher Sci 42: 247-251, 2010.
51. Ristow SC, Griner PF, Abraham GN and Shoulson I: Reversal of systemic manifestations of cryoglobulinemia: Treatment with melphalan and prednisone. Arch Intern Med 136: 467-470, 1976.
52. Frankel AH, Singer DR, Winearls CG, et al: Type II essential mixed cryoglobulinaemia: presentation, treatment and outcome in 13 patients. Q J Med 82: 101-124, 1992.
53. D'Amico G, Colasanti G, Ferrario F and Sinico RA: Renal involvement in essential mixed cryoglobulinemia. Kidney Int 35: 1004-1014, 1989. (Pubitemid 19099714)
54. Madore F, Lazarus JM and Brady HR: Therapeutic plasma exchange in renal diseases. J Am Soc Nephrol 7: 367-386, 1996. (Pubitemid 26128308)
55. Guillevin L and Pagnoux C: Indications of plasma exchanges for systemic vasculitides. Ther Apher Dial 7: 155-160, 2003. (Pubitemid 36753910)
56. Misiani R, Bellavita P, Baio P, et al: Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-alpha and ribavirin. Nephrol Dial Transplant 14: 1558-1560, 1999. (Pubitemid 29241756)
57. Zuckerman E, Keren D, Slobodin G, et al: Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. J Rheumatol 27: 2172-2178, 2000.
58. Mazzaro C, Zorat F, Caizzi M, et al: Treatment with peginterferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. J Hepatol 42: 632-638, 2005.
59. Cacoub P, Saadoun D, Limal N, et al: PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 52: 911-915, 2005. (Pubitemid 40365115)
60. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R; European Vasculitis Study Group: EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68: 310-317, 2009.
61. Sansonno D, De Re V, Lauletta G, et al: Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood 101: 3818-3826, 2003. (Pubitemid 36857852)
62. Zaja F, De Vita S, Mazzaro C, et al: Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 101: 3827-3834, 2003. (Pubitemid 36857853)
63. Quartuccio L, Soardo G, Romano G, et al: Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Rheumatology (Oxford) 45: 842-846, 2006. (Pubitemid 43985372)
64. Saadoun D, Resche Rigon M, Sene D, Terrier B, Karras A, Perard L, Schoindre Y, Coppéré B, Blanc F, Musset L, Piette JC, Rosenzwajg M and Cacoub P: Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon a/ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood 116: 326-334, 2010.
65. Sawabe T, Uenotsuchi T, Imafuku S, et al: Remission of hepatitis B virus-related vasculitis with lamivudine. Ann Intern Med 140: 672-673, 2004. (Pubitemid 38500464)
66. Stecevic V, Pevzner MM and Gordon SC: Successful treatment of hepatitis B-associated vasculitis with lamivudine. J Clin Gastroenterol 36: 451, 2003. (Pubitemid 36459147)
67. Kawakami T, Ooka S, Mizoguchi M, et al: Remission of hepatitis B virus-related cryoglobulinemic vasculitis with entecavir. Ann Intern Med 149: 911-912, 2008.
68. Enomoto M, Nakanishi T, Nakamishi T, et al: Entecavir to treat hepatitis B-associated cryoglobulinemic vasculitis. Ann Intern Med 149: 912-913, 2008.
69. Della Rossa A, Marchi F, Catarsi E, et al: Mixed cryoglobulinemia and mortality: a review of the literature. Clin Exp Rheum 26: S105-S108, 2008.
70. Kordossis T, Sipsas NV, Kontos A, et al: Mixed cryoglobulinemia is associated with increased risk for death, or neoplasia in HIV-1 infection. Eur J Clin Invest 31: 1078-1082, 2001.
71. Ferri C, Sebastiani M, Giuggioli D, et al: Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum Jun 33: 355-374, 2004.
72. Bryce AH, Kyle RA, Dispenzieri A, et al: Natural history and therapy of 66 patients with mixed cryoglobulinemia. Am J Hematol Jul 81: 511-518, 2006.
73. Saadoun D, Resche-Rigon M, Thibault V, et al: Antiviral therapy for hepatitis C virus - associated mixed cryoglobulinemia vasculitis: a long-term followup study. Arthritis Rheum 54: 3696-3706, 2006. (Pubitemid 44737183)
74. Saccardo E, Novati P, Sironi D, et al: Causes of death in symptomatic cryoglobulinemia: 30 years of observation in a Department of Internal Medicine. Dig Liver Dis 39: S52-S54, 2007. (Pubitemid 47528194)
75. Landau DA, Scerra S, Sene D, et al: Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy. J Rheumatol Mar 37: 615-621, 2010.
76. Della Rossa A, Tavoni A, D'Ascanio A, et al: Mortality rate and outcome factors in mixed cryoglobulinaemia: the impact of hepatitis C virus. Scand J Rheumatol Mar 39: 167-170, 2010.
77. Levine JW, Gota C, Fessler BJ, et al: Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus. J Rheumatol 32: 1164-1167, 2005. (Pubitemid 40828106)